Clinical Challenges
ASCO: Non-Small Cell Lung Cancer
American Society of Clinical Oncology
More in ASCO: Non-Small Cell Lung Cancer
The immune-related adverse event is rare and manageable, but not necessarily reversible
Jun 25, 2021
The immune-related adverse event is rare and manageable, but not necessarily reversible